Company / Current Assets
Edwards Lifesciences Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$6.7B
FY2025
5-year range
$3.1B / $6.7B
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#23 of 160
Health Care
What the data says
Edwards Lifesciences's current assets of $6.7B is higher than 86% of companies in the Health Care sector (FY2025). Current Assets has increased for 3 consecutive years, from $3.1B in FY2022 to $6.7B in FY2025.
Based on SEC 10-K filings.
$6.7B in FY2025 with a 5-year CAGR of +16.9%. Top quartile in the Health Care sector.
Improved from $4.0B to $6.7B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +29.6%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 160This company $6.7B Sector average $5.2B
▼
+28.7% above sector average
Key checks
Key Insights
- Edwards Lifesciences's current assets has grown for 3 consecutive years.
- 5-year CAGR of +16.9%, indicating consistent growth.
- In FY2025, current assets increased 7.2% year-over-year.
- Ranks #23 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.7B | +7.2% |
| FY2024 | $6.3B | +55.7% |
| FY2023 | $4.0B | +30.4% |
| FY2022 | $3.1B | -2.7% |
| FY2021 | $3.2B | +2.9% |
| FY2020 | $3.1B | +3.6% |
| FY2019 | $3.0B | +30.5% |
| FY2018 | $2.3B | -10.3% |
| FY2017 | $2.5B | +13.8% |
| FY2016 | $2.2B | +9.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026